Global Rapid Point-of-Care (PoC) Diagnostics 麻豆原创 2024 by Company, Regions, Type and Application, Forecast to 2030

Publication ID:

GIR072402175

Publication Date:

July 3, 2024

Pages:

103

Publisher:

GIR

Countries:

Global [1]

USD 3,480.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

The global Rapid Point-of-Care (PoC) Diagnostics market size was valued at USD 26410 million in 2023 and is forecast to a readjusted size of USD 35250 million by 2030 with a CAGR of 4.2% during review period.
Point-of-care (POC) diagnostics provide rapid actionable information for patient care at the time and site of an encounter with the health care system.
This report includes an overview of the development of the Rapid Point-of-Care (PoC) Diagnostics industry chain, the market status of Clinics (Instrument Systems, Tests Software & Services), Hospitals (Instrument Systems, Tests Software & Services), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Rapid Point-of-Care (PoC) Diagnostics.
Regionally, the report analyzes the Rapid Point-of-Care (PoC) Diagnostics markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Rapid Point-of-Care (PoC) Diagnostics market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Rapid Point-of-Care (PoC) Diagnostics market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Rapid Point-of-Care (PoC) Diagnostics industry.
The report involves analyzing the market at a macro level:
麻豆原创 Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Instrument Systems, Tests Software & Services).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Rapid Point-of-Care (PoC) Diagnostics market.
Regional Analysis: The report involves examining the Rapid Point-of-Care (PoC) Diagnostics market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
麻豆原创 Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Rapid Point-of-Care (PoC) Diagnostics market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Rapid Point-of-Care (PoC) Diagnostics:
Company Analysis: Report covers individual Rapid Point-of-Care (PoC) Diagnostics players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Rapid Point-of-Care (PoC) Diagnostics This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Clinics, Hospitals).
Technology Analysis: Report covers specific technologies relevant to Rapid Point-of-Care (PoC) Diagnostics. It assesses the current state, advancements, and potential future developments in Rapid Point-of-Care (PoC) Diagnostics areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Rapid Point-of-Care (PoC) Diagnostics market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
麻豆原创 Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
麻豆原创 Segmentation
Rapid Point-of-Care (PoC) Diagnostics market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
麻豆原创 segment by Type
Instrument Systems
Tests Software & Services
麻豆原创 segment by Application
Clinics
Hospitals
Laboratory
Others
麻豆原创 segment by players, this report covers
Abbott
Roche
Danaher
Siemens Healthineers
BD
Quidel
Bio-Rad
BioMerieux
Abaxis
Chembio
Sekisui Diagnostics
EKF Diagnostics
Trinity Biotech
麻豆原创 segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Rapid Point-of-Care (PoC) Diagnostics product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Rapid Point-of-Care (PoC) Diagnostics, with revenue, gross margin and global market share of Rapid Point-of-Care (PoC) Diagnostics from 2019 to 2024.
Chapter 3, the Rapid Point-of-Care (PoC) Diagnostics competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Rapid Point-of-Care (PoC) Diagnostics market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Rapid Point-of-Care (PoC) Diagnostics.
Chapter 13, to describe Rapid Point-of-Care (PoC) Diagnostics research findings and conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.

Table Of Contents:

1 麻豆原创 Overview
1.1 Product Overview and Scope of Rapid Point-of-Care (PoC) Diagnostics
1.2 麻豆原创 Estimation Caveats and Base Year
1.3 Classification of Rapid Point-of-Care (PoC) Diagnostics by Type
1.3.1 Overview: Global Rapid Point-of-Care (PoC) Diagnostics 麻豆原创 Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Rapid Point-of-Care (PoC) Diagnostics Consumption Value 麻豆原创 Share by Type in 2023
1.3.3 Instrument Systems
1.3.4 Tests Software & Services
1.4 Global Rapid Point-of-Care (PoC) Diagnostics 麻豆原创 by Application
1.4.1 Overview: Global Rapid Point-of-Care (PoC) Diagnostics 麻豆原创 Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Clinics
1.4.3 Hospitals
1.4.4 Laboratory
1.4.5 Others
1.5 Global Rapid Point-of-Care (PoC) Diagnostics 麻豆原创 Size & Forecast
1.6 Global Rapid Point-of-Care (PoC) Diagnostics 麻豆原创 Size and Forecast by Region
1.6.1 Global Rapid Point-of-Care (PoC) Diagnostics 麻豆原创 Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Rapid Point-of-Care (PoC) Diagnostics 麻豆原创 Size by Region, (2019-2030)
1.6.3 North America Rapid Point-of-Care (PoC) Diagnostics 麻豆原创 Size and Prospect (2019-2030)
1.6.4 Europe Rapid Point-of-Care (PoC) Diagnostics 麻豆原创 Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Rapid Point-of-Care (PoC) Diagnostics 麻豆原创 Size and Prospect (2019-2030)
1.6.6 South America Rapid Point-of-Care (PoC) Diagnostics 麻豆原创 Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Rapid Point-of-Care (PoC) Diagnostics 麻豆原创 Size and Prospect (2019-2030)
2 Company Profiles
2.1 Abbott
2.1.1 Abbott Details
2.1.2 Abbott Major Business
2.1.3 Abbott Rapid Point-of-Care (PoC) Diagnostics Product and Solutions
2.1.4 Abbott Rapid Point-of-Care (PoC) Diagnostics Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.1.5 Abbott Recent Developments and Future Plans
2.2 Roche
2.2.1 Roche Details
2.2.2 Roche Major Business
2.2.3 Roche Rapid Point-of-Care (PoC) Diagnostics Product and Solutions
2.2.4 Roche Rapid Point-of-Care (PoC) Diagnostics Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.2.5 Roche Recent Developments and Future Plans
2.3 Danaher
2.3.1 Danaher Details
2.3.2 Danaher Major Business
2.3.3 Danaher Rapid Point-of-Care (PoC) Diagnostics Product and Solutions
2.3.4 Danaher Rapid Point-of-Care (PoC) Diagnostics Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.3.5 Danaher Recent Developments and Future Plans
2.4 Siemens Healthineers
2.4.1 Siemens Healthineers Details
2.4.2 Siemens Healthineers Major Business
2.4.3 Siemens Healthineers Rapid Point-of-Care (PoC) Diagnostics Product and Solutions
2.4.4 Siemens Healthineers Rapid Point-of-Care (PoC) Diagnostics Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.4.5 Siemens Healthineers Recent Developments and Future Plans
2.5 BD
2.5.1 BD Details
2.5.2 BD Major Business
2.5.3 BD Rapid Point-of-Care (PoC) Diagnostics Product and Solutions
2.5.4 BD Rapid Point-of-Care (PoC) Diagnostics Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.5.5 BD Recent Developments and Future Plans
2.6 Quidel
2.6.1 Quidel Details
2.6.2 Quidel Major Business
2.6.3 Quidel Rapid Point-of-Care (PoC) Diagnostics Product and Solutions
2.6.4 Quidel Rapid Point-of-Care (PoC) Diagnostics Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.6.5 Quidel Recent Developments and Future Plans
2.7 Bio-Rad
2.7.1 Bio-Rad Details
2.7.2 Bio-Rad Major Business
2.7.3 Bio-Rad Rapid Point-of-Care (PoC) Diagnostics Product and Solutions
2.7.4 Bio-Rad Rapid Point-of-Care (PoC) Diagnostics Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.7.5 Bio-Rad Recent Developments and Future Plans
2.8 BioMerieux
2.8.1 BioMerieux Details
2.8.2 BioMerieux Major Business
2.8.3 BioMerieux Rapid Point-of-Care (PoC) Diagnostics Product and Solutions
2.8.4 BioMerieux Rapid Point-of-Care (PoC) Diagnostics Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.8.5 BioMerieux Recent Developments and Future Plans
2.9 Abaxis
2.9.1 Abaxis Details
2.9.2 Abaxis Major Business
2.9.3 Abaxis Rapid Point-of-Care (PoC) Diagnostics Product and Solutions
2.9.4 Abaxis Rapid Point-of-Care (PoC) Diagnostics Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.9.5 Abaxis Recent Developments and Future Plans
2.10 Chembio
2.10.1 Chembio Details
2.10.2 Chembio Major Business
2.10.3 Chembio Rapid Point-of-Care (PoC) Diagnostics Product and Solutions
2.10.4 Chembio Rapid Point-of-Care (PoC) Diagnostics Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.10.5 Chembio Recent Developments and Future Plans
2.11 Sekisui Diagnostics
2.11.1 Sekisui Diagnostics Details
2.11.2 Sekisui Diagnostics Major Business
2.11.3 Sekisui Diagnostics Rapid Point-of-Care (PoC) Diagnostics Product and Solutions
2.11.4 Sekisui Diagnostics Rapid Point-of-Care (PoC) Diagnostics Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.11.5 Sekisui Diagnostics Recent Developments and Future Plans
2.12 EKF Diagnostics
2.12.1 EKF Diagnostics Details
2.12.2 EKF Diagnostics Major Business
2.12.3 EKF Diagnostics Rapid Point-of-Care (PoC) Diagnostics Product and Solutions
2.12.4 EKF Diagnostics Rapid Point-of-Care (PoC) Diagnostics Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.12.5 EKF Diagnostics Recent Developments and Future Plans
2.13 Trinity Biotech
2.13.1 Trinity Biotech Details
2.13.2 Trinity Biotech Major Business
2.13.3 Trinity Biotech Rapid Point-of-Care (PoC) Diagnostics Product and Solutions
2.13.4 Trinity Biotech Rapid Point-of-Care (PoC) Diagnostics Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.13.5 Trinity Biotech Recent Developments and Future Plans
3 麻豆原创 Competition, by Players
3.1 Global Rapid Point-of-Care (PoC) Diagnostics Revenue and Share by Players (2019-2024)
3.2 麻豆原创 Share Analysis (2023)
3.2.1 麻豆原创 Share of Rapid Point-of-Care (PoC) Diagnostics by Company Revenue
3.2.2 Top 3 Rapid Point-of-Care (PoC) Diagnostics Players 麻豆原创 Share in 2023
3.2.3 Top 6 Rapid Point-of-Care (PoC) Diagnostics Players 麻豆原创 Share in 2023
3.3 Rapid Point-of-Care (PoC) Diagnostics 麻豆原创: Overall Company Footprint Analysis
3.3.1 Rapid Point-of-Care (PoC) Diagnostics 麻豆原创: Region Footprint
3.3.2 Rapid Point-of-Care (PoC) Diagnostics 麻豆原创: Company Product Type Footprint
3.3.3 Rapid Point-of-Care (PoC) Diagnostics 麻豆原创: Company Product Application Footprint
3.4 New 麻豆原创 Entrants and Barriers to 麻豆原创 Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 麻豆原创 Size Segment by Type
4.1 Global Rapid Point-of-Care (PoC) Diagnostics Consumption Value and 麻豆原创 Share by Type (2019-2024)
4.2 Global Rapid Point-of-Care (PoC) Diagnostics 麻豆原创 Forecast by Type (2025-2030)
5 麻豆原创 Size Segment by Application
5.1 Global Rapid Point-of-Care (PoC) Diagnostics Consumption Value 麻豆原创 Share by Application (2019-2024)
5.2 Global Rapid Point-of-Care (PoC) Diagnostics 麻豆原创 Forecast by Application (2025-2030)
6 North America
6.1 North America Rapid Point-of-Care (PoC) Diagnostics Consumption Value by Type (2019-2030)
6.2 North America Rapid Point-of-Care (PoC) Diagnostics Consumption Value by Application (2019-2030)
6.3 North America Rapid Point-of-Care (PoC) Diagnostics 麻豆原创 Size by Country
6.3.1 North America Rapid Point-of-Care (PoC) Diagnostics Consumption Value by Country (2019-2030)
6.3.2 United States Rapid Point-of-Care (PoC) Diagnostics 麻豆原创 Size and Forecast (2019-2030)
6.3.3 Canada Rapid Point-of-Care (PoC) Diagnostics 麻豆原创 Size and Forecast (2019-2030)
6.3.4 Mexico Rapid Point-of-Care (PoC) Diagnostics 麻豆原创 Size and Forecast (2019-2030)
7 Europe
7.1 Europe Rapid Point-of-Care (PoC) Diagnostics Consumption Value by Type (2019-2030)
7.2 Europe Rapid Point-of-Care (PoC) Diagnostics Consumption Value by Application (2019-2030)
7.3 Europe Rapid Point-of-Care (PoC) Diagnostics 麻豆原创 Size by Country
7.3.1 Europe Rapid Point-of-Care (PoC) Diagnostics Consumption Value by Country (2019-2030)
7.3.2 Germany Rapid Point-of-Care (PoC) Diagnostics 麻豆原创 Size and Forecast (2019-2030)
7.3.3 France Rapid Point-of-Care (PoC) Diagnostics 麻豆原创 Size and Forecast (2019-2030)
7.3.4 United Kingdom Rapid Point-of-Care (PoC) Diagnostics 麻豆原创 Size and Forecast (2019-2030)
7.3.5 Russia Rapid Point-of-Care (PoC) Diagnostics 麻豆原创 Size and Forecast (2019-2030)
7.3.6 Italy Rapid Point-of-Care (PoC) Diagnostics 麻豆原创 Size and Forecast (2019-2030)
8 Asia-Pacific
8.1 Asia-Pacific Rapid Point-of-Care (PoC) Diagnostics Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Rapid Point-of-Care (PoC) Diagnostics Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Rapid Point-of-Care (PoC) Diagnostics 麻豆原创 Size by Region
8.3.1 Asia-Pacific Rapid Point-of-Care (PoC) Diagnostics Consumption Value by Region (2019-2030)
8.3.2 China Rapid Point-of-Care (PoC) Diagnostics 麻豆原创 Size and Forecast (2019-2030)
8.3.3 Japan Rapid Point-of-Care (PoC) Diagnostics 麻豆原创 Size and Forecast (2019-2030)
8.3.4 South Korea Rapid Point-of-Care (PoC) Diagnostics 麻豆原创 Size and Forecast (2019-2030)
8.3.5 India Rapid Point-of-Care (PoC) Diagnostics 麻豆原创 Size and Forecast (2019-2030)
8.3.6 Southeast Asia Rapid Point-of-Care (PoC) Diagnostics 麻豆原创 Size and Forecast (2019-2030)
8.3.7 Australia Rapid Point-of-Care (PoC) Diagnostics 麻豆原创 Size and Forecast (2019-2030)
9 South America
9.1 South America Rapid Point-of-Care (PoC) Diagnostics Consumption Value by Type (2019-2030)
9.2 South America Rapid Point-of-Care (PoC) Diagnostics Consumption Value by Application (2019-2030)
9.3 South America Rapid Point-of-Care (PoC) Diagnostics 麻豆原创 Size by Country
9.3.1 South America Rapid Point-of-Care (PoC) Diagnostics Consumption Value by Country (2019-2030)
9.3.2 Brazil Rapid Point-of-Care (PoC) Diagnostics 麻豆原创 Size and Forecast (2019-2030)
9.3.3 Argentina Rapid Point-of-Care (PoC) Diagnostics 麻豆原创 Size and Forecast (2019-2030)
10 Middle East & Africa
10.1 Middle East & Africa Rapid Point-of-Care (PoC) Diagnostics Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Rapid Point-of-Care (PoC) Diagnostics Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Rapid Point-of-Care (PoC) Diagnostics 麻豆原创 Size by Country
10.3.1 Middle East & Africa Rapid Point-of-Care (PoC) Diagnostics Consumption Value by Country (2019-2030)
10.3.2 Turkey Rapid Point-of-Care (PoC) Diagnostics 麻豆原创 Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Rapid Point-of-Care (PoC) Diagnostics 麻豆原创 Size and Forecast (2019-2030)
10.3.4 UAE Rapid Point-of-Care (PoC) Diagnostics 麻豆原创 Size and Forecast (2019-2030)
11 麻豆原创 Dynamics
11.1 Rapid Point-of-Care (PoC) Diagnostics 麻豆原创 Drivers
11.2 Rapid Point-of-Care (PoC) Diagnostics 麻豆原创 Restraints
11.3 Rapid Point-of-Care (PoC) Diagnostics Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 Industry Chain Analysis
12.1 Rapid Point-of-Care (PoC) Diagnostics Industry Chain
12.2 Rapid Point-of-Care (PoC) Diagnostics Upstream Analysis
12.3 Rapid Point-of-Care (PoC) Diagnostics Midstream Analysis
12.4 Rapid Point-of-Care (PoC) Diagnostics Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

Companies Mentioned:

Abbott
Roche
Danaher
Siemens Healthineers
BD
Quidel
Bio-Rad
BioMerieux
Abaxis
Chembio
Sekisui Diagnostics
EKF Diagnostics
Trinity Biotech

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.